Translation

Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any discrepancy between this translated document and the original Japanese document, the latter shall prevail.

Summary of Non-Consolidated Financial Results

for the Year Ended March 31, 2021

(Based on Japanese GAAP)

May 13, 2021

Company name:

RIBOMIC Inc.

Stock exchange listing:

Tokyo

Stock code:

4591

URL https://www.ribomic.com/

Representative:

President and CEO

Yoshikazu Nakamura

Inquiries:

Corporate Officer Finance and Accounting

Shoji Yonebayashi

TEL 03(3440)3745

Department

Scheduled date of ordinary general meeting of shareholders:

June 29, 2021

Scheduled date to file Securities Report:

June 30, 2021

Scheduled date to commence dividend payments:

-

Preparation of supplementary material on financial results:

Yes

Holding of financial results meeting:

Yes

(for institutional investors and analysts)

(Amounts less than one million yen are rounded down)

1. Non-consolidated financial results for the year ended March 31, 2021 (from April 1, 2020 to March 31, 2021)

(1) Non-consolidated operating results

Percentages indicate year-on-year changes

Operating revenues

Operating income

Ordinary income

Profit

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Year ended March 31, 2021

91

(24.2)

(1,239)

-

(1,184)

-

(1,187)

-

Year ended March 31, 2020

121

-

(914)

-

(853)

-

(855)

-

Earnings per share

Diluted earnings per

Profit/equity

Ordinary

Operating

share

income/total assets

income/net revenues

Yen

Yen

%

%

%

Year ended March 31, 2021

(46.17)

-

(29.1)

(28.2)

-

Year ended March 31, 2020

(53.62)

-

(46.9)

(35.3)

(753.5)

Reference: Share of income of investments accounted for using the equity method.

Year ended March 31, 2021

¥ - Million

Year ended March 31, 2020

¥ - Million

Note: Diluted earnings per share is not shown because a net loss per share was incurred even though dilutive common shares exist.

(2) Non-consolidated financial position

Total assets

Net assets

Equity ratio

Net assets per share

Millions of yen

Millions of yen

%

Yen

As of March 31, 2021

6,119

6,002

98.1

215.04

As of March 31, 2020

2,269

2,180

95.3

123.27

Reference: Equity

As of March 31, 2021

¥6,001

Million

As of March 31, 2020

¥2,164 Million

(3) Non-consolidated cash flows

Cash flows from

Cash flows from

Cash flows from

Cash and cash equivalents

operating activities

investing activities

financing activities

at end of period

Millions of yen

Millions of yen

Millions of yen

Millions of yen

Year ended March 31, 2021

(1,149)

(1,699)

4,988

3,338

Year ended March 31, 2020

(902)

553

536

1,199

1

2. Cash dividends

Annual dividends per share

Total cash

Dividend payout

Ratio of dividends

ratio (Non-

to net assets (Non-

1st quarter-end

2nd quarter-end

3rd quarter-end

Fiscal year-end

Total

dividends (Total)

consolidated)

consolidated)

Yen

Yen

Yen

Yen

Yen

Millions of yen

%

%

Year ended March 31, 2020

-

0.00

-

0.00

0.00

-

-

-

Year ended March 31, 2021

-

0.00

-

0.00

0.00

-

-

-

Year ending March 31, 2022

-

0.00

-

0.00

0.00

-

(Forecast)

3. Forecast of non-consolidated financial results for the year ending March 31, 2022 (from April 1, 2021 to March 31, 2022)

Percentages indicate year-on-year changes

Operating revenues

Operating income

Ordinary income

Profit

Earnings per share

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Yen

Full year

80

(11.9)

(2,495)

-

(2,391)

-

(2,393)

-

(85.75)

Note: The Company only provides full-year forecasts as it manages its performance on an annual basis.

4. Notes

(1) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements

Changes in accounting policies due to revisions to accounting standards and other regulations:

No

Changes in accounting policies due to other reasons:

No

Changes in accounting estimates:

No

Restatement of prior period financial statements:

No

(2) Number of issued shares (common shares)

Total number of issued shares at the end of the period (including treasury shares)

As of March 31, 2021

27,908,784

shares

As of March 31, 2020

17,555,784

shares

Number of treasury shares at the end of the period

As of March 31, 2021

- shares

As of March 31, 2020

- shares

Average number of shares during the period

Year ended March 31, 2021

25,712,891

shares

Year ended March 31, 2020

15,944,883

shares

  • This financial results report is exempt from the audit procedures.
  • Explanation on appropriate use of business forecasts, and other special notes.

1.Business forecasts and other forward-looking statements contained in this report are based on information currently available to the company and on certain assumptions that the company considers to be reasonable, and do not constitute guarantees of future performance. Actual results may differ significantly from these forecasts due to various factors.

  1. Supplementary materials are disclosed via TDnet and available on the company's website.
  2. The company plans to hold a financial results meeting for institutional investors and analysts on May 14, 2021.

2

Non-consolidated financial statements

Non-consolidated balance sheets

(Thousands of yen)

As of March 31, 2020

As of March 31, 2021

Assets

Current assets

Cash and deposits

1,601,728

3,338,038

Accounts receivable - trade

108,830

-

Securities

399,994

2,500,000

Supplies

6,364

3,038

Advance payments - trade

2,390

153,984

Prepaid expenses

18,764

18,358

Accounts receivable - other

1,831

201

Consumption taxes receivable

34,028

35,894

Other

1,661

823

Total current assets

2,175,594

6,050,339

Non-current assets

Property, plant and equipment

Buildings

22,555

22,851

Accumulated depreciation

(14,415)

(15,220)

Buildings, net

8,139

7,631

Tools, furniture and fixtures

270,053

268,436

Accumulated depreciation

(222,380)

(245,336)

Tools, furniture and fixtures, net

47,673

23,099

Total property, plant and equipment

55,812

30,731

Intangible assets

Software

1,626

151

Total intangible assets

1,626

151

Investments and other assets

Shares of subsidiaries and associates

22,552

22,552

Leasehold deposits

13,560

12,800

Long-term prepaid expenses

591

3,085

Total investments and other assets

36,704

38,438

Total non-current assets

94,143

69,320

Total assets

2,269,737

6,119,660

Liabilities

Current liabilities

Accounts payable - other

24,230

43,357

Accrued expenses

10,202

11,137

Income taxes payable

28,038

39,537

Advances received

6,875

3,666

Deposits received

6,442

6,262

Other

13,000

13,000

Total current liabilities

88,788

116,960

Total liabilities

88,788

116,960

3

(Thousands of yen)

As of March 31, 2020

As of March 31, 2021

Net assets

Shareholders' equity

Capital Stock

4,029,956

6,542,185

Capital surplus

Legal capital surplus

4,002,956

6,515,185

Total capital surpluses

4,002,956

6,515,185

Retained earnings

Other retained earnings

Retained earnings brought forward

(5,868,737)

(7,055,932)

Total retained earnings

(5,868,737)

(7,055,932)

Total shareholders' equity

2,164,174

6,001,438

Share acquisition rights

16,773

1,261

Total net assets

2,180,948

6,002,699

Total liabilities and net assets

2,269,737

6,119,660

4

Non-consolidated statements of income

(Thousands of yen)

Fiscal year ended

Fiscal year ended

March 31, 2020

March 31, 2021

Operating revenues

121,385

91,963

Operating expenses

Research and development expenses

673,605

957,605

Selling, general and administrative expenses

362,360

374,000

Total operating expenses

1,035,965

1,331,606

Operating loss

(914,580)

(1,239,643)

Non-operating income

Interest income

993

248

Subsidy income

74,855

82,727

Other

1,203

1,221

Total non-operating income

77,053

84,196

Non-operating expenses

Share issuance cost

14,305

20,414

Loss on redemption of bonds

2,000

-

Foreign exchange losses

-

9,137

Total non-operating expenses

16,305

29,552

Ordinary loss

(853,832)

(1,184,998)

Extraordinary losses

Loss on retirement of non-current assets

-

985

Total extraordinary losses

-

985

Loss before income taxes

(853,832)

(1,185,984)

Income taxes - current

1,210

1,210

Total income taxes

1,210

1,210

Loss

(855,042)

(1,187,194)

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Ribomic Inc. published this content on 25 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 May 2021 08:46:02 UTC.